Internal Medicine, Hematology & Oncology · Southampton, NY
NPI
1417999533
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
640 County Road 39
Southampton, NY, 11968
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.2M
279,356 services
Medicare patients, 2024
1,585
Average age 76
Drug cost, 2024
$8.9M
3,007 prescriptions
Company payments, 2024
$144
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Louis J Avvento was code J1439 (injection, ferric carboxymaltose, 1 mg), 84,000 times for 86 patients. In total Louis J Avvento billed 279,356 services in 289 codes, and Medicare paid $4.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 84,000 | 86 | $0.87 | $73K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 30,400 | 33 | $2.31 | $70K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,800 | 18 | $44.86 | $754K |
| J0897 Injection, denosumab, 1 mg | Office | 9,900 | 63 | $20.65 | $204K |
| J1756 Injection, iron sucrose, 1 mg | Office | 6,400 | 25 | $0.17 | $1,117 |
| 88185 Surgical Pathology Examination | Office | 6,356 | 195 | $22.20 | $141K |
| 36415 Venipuncture Blood Collection | Office | 4,440 | 1,414 | $8.65 | $38K |
| 85025 Blood Count | Office | 4,387 | 1,366 | $7.61 | $33K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,190 | 15 | $36.23 | $152K |
| 80053 Clinical Chemistry | Office | 3,135 | 1,231 | $10.35 | $32K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,111 | 108 | $0.09 | $272 |
| 83615 Clinical Chemistry | Office | 2,158 | 917 | $5.92 | $13K |
| 83735 Clinical Chemistry | Office | 2,136 | 914 | $6.57 | $14K |
| 84550 Clinical Chemistry | Office | 2,010 | 872 | $4.43 | $8,900 |
| 99214 Office E&M - Established | Office | 1,909 | 862 | $110.31 | $211K |
By year: 2022 $5.6M for 328,521 services; 2023 $4.2M for 262,747 services; 2024 $4.2M for 279,356 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 6,356 | 195 | $22.20 | $141K |
| 36415 Venipuncture Blood Collection | 4,440 | 1,414 | $8.65 | $38K |
| 85025 Blood Count | 4,387 | 1,366 | $7.61 | $33K |
| 80053 Clinical Chemistry | 3,135 | 1,231 | $10.35 | $32K |
| 83615 Clinical Chemistry | 2,158 | 917 | $5.92 | $13K |
| 83735 Clinical Chemistry | 2,136 | 914 | $6.57 | $14K |
| 84550 Clinical Chemistry | 2,010 | 872 | $4.43 | $8,900 |
| 84100 Clinical Chemistry | 1,898 | 849 | $4.65 | $8,823 |
| 82728 Clinical Chemistry | 1,561 | 773 | $13.36 | $21K |
| 83540 Clinical Chemistry | 1,496 | 738 | $6.34 | $9,485 |
Medicare prescription drug claims, 2024
In 2024, the drug Louis J Avvento prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 297 prescriptions and refills. In total Louis J Avvento wrote 3,007 Medicare prescriptions that cost $8.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 297 | 297 | 72 | $1.1M |
| Eliquis Apixaban | 200 | 259 | 37 | $142K |
| Letrozole Generic | 129 | 264 | 36 | $1,933 |
| Akynzeo Fosnetupitant/Palonosetron | 101 | 102 | 28 | $129K |
| Prednisone Generic | 75 | 89 | 37 | $362 |
| Anastrozole Generic | 67 | 124 | 15 | $814 |
| Lupron Depot Leuprolide Acetate | 59 | 175 | 19 | $333K |
| Procrit Epoetin Alfa | 57 | 57 | 12 | $190K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 56 | 56 | Under 11 | $511K |
| Hydroxyurea Generic | 54 | 105 | 16 | $927 |
| Xtandi Enzalutamide | 52 | 52 | Under 11 | $712K |
| Bicalutamide Generic | 51 | 65 | Under 11 | $1,110 |
| Xarelto Rivaroxaban | 50 | 76 | 14 | $41K |
| Allopurinol Generic | 49 | 59 | 20 | $239 |
| Dexamethasone Generic | 48 | 55 | 27 | $628 |
Brand drugs: - claims; generic drugs: 1,534 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Louis J Avvento $144 ($144 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.